(Q35562157)

8 August 2017

Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure (English)

1 reference

8 August 2017

1 reference

4

Michael S Lauer

1 reference

8 August 2017

David W Baker

1

1 reference

8 August 2017

Robert C Bahler

series ordinal

2

1 reference

8 August 2017

Robert S Finkelhor

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

American Heart Journal

1 reference

8 August 2017

146

1 reference

8 August 2017

736-740

1 reference

8 August 2017

4

1 reference

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Biochemical detection of left-ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Prevention of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

The progression from hypertension to congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

The epidemiology of heart failure: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Role of blood pressure in the development of congestive heart failure. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Epidemiology and prevention of cardiac failure: Framingham Study insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Epidemiology of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Ten-year risk of false positive screening mammograms and clinical breast examinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Beta-blockers: the new standard of therapy for mild heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900396-X

10.1016/S0002-8703(03)00396-X

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference